Mirtazapine Tablet, Film Coated
Product Images NDC 68071-2635

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 68071-2635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2635 9)

Pdp (68071 2635 9)
Label for Mirtazapine 30 mg tablets from NuCare Pharmaceuticals, Inc. The label states a quantity of 90 tablets. The tablets are described as capsule-shaped, reddish brown, with a score line between 0 and 9 on one side and an 'A' debossed on the other. The label includes the NDC 68071-2635-9 and product number P1685090. Storage instructions are to keep the product at controlled temperature 68-77°F. A warning to keep out of reach of children is also present.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)
Chemical structure diagram of Mirtazapine, the active ingredient in the product. The structure shows the molecular framework with rings and nitrogen atoms as part of its configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.